CO6541539A2 - Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas - Google Patents

Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas

Info

Publication number
CO6541539A2
CO6541539A2 CO12097489A CO12097489A CO6541539A2 CO 6541539 A2 CO6541539 A2 CO 6541539A2 CO 12097489 A CO12097489 A CO 12097489A CO 12097489 A CO12097489 A CO 12097489A CO 6541539 A2 CO6541539 A2 CO 6541539A2
Authority
CO
Colombia
Prior art keywords
crystal forms
crystalline form
ilaprazole
preparing
ilaprazol
Prior art date
Application number
CO12097489A
Other languages
English (en)
Spanish (es)
Inventor
Dong Yeong Kim
Jae Soo Shin
Jung Yeong Lee
Kwi Hyung Cho
Sung Tae Park
Jung Woo Kim
Sang Don Nam
Hee Yun Kim
Original Assignee
Ilyang Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilyang Pharm Co Ltd filed Critical Ilyang Pharm Co Ltd
Publication of CO6541539A2 publication Critical patent/CO6541539A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
CO12097489A 2009-12-08 2012-06-08 Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas CO6541539A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090121209A KR101144600B1 (ko) 2009-12-08 2009-12-08 일라프라졸의 결정형 ａ, ｂ의 제조방법 및 이들 결정형의 변환방법

Publications (1)

Publication Number Publication Date
CO6541539A2 true CO6541539A2 (es) 2012-10-16

Family

ID=44146052

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12097489A CO6541539A2 (es) 2009-12-08 2012-06-08 Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas

Country Status (7)

Country Link
KR (1) KR101144600B1 (ru)
BR (1) BR112012012212A2 (ru)
CO (1) CO6541539A2 (ru)
EA (1) EA019058B1 (ru)
IN (1) IN2012DN03176A (ru)
UA (1) UA102787C2 (ru)
WO (1) WO2011071314A2 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103204842B (zh) * 2012-01-13 2014-10-15 丽珠医药集团股份有限公司 结晶型艾普拉唑钠水合物及其制备方法
CN103204843B (zh) * 2012-01-13 2014-12-31 丽珠医药集团股份有限公司 结晶型艾普拉唑钠乙醇化物及其制备方法
WO2013114232A1 (en) 2012-02-02 2013-08-08 Lupin Limited Process for preparation of crystalline form l of ilaprazole
CN102746277B (zh) * 2012-06-21 2014-05-14 丽珠医药集团股份有限公司 一种结晶形式的艾普拉唑钠及其制备方法
CN102746275B (zh) * 2012-06-21 2014-07-16 丽珠医药集团股份有限公司 结晶型艾普拉唑钠及其制备方法
CN102746276B (zh) * 2012-06-21 2014-07-02 丽珠医药集团股份有限公司 一种艾普拉唑钠晶型及其制备方法
CN113045544A (zh) * 2014-09-04 2021-06-29 江苏奥赛康药业有限公司 艾普拉唑钠化合物及其药物组合物
CN115403560A (zh) * 2017-11-06 2022-11-29 丽珠医药集团股份有限公司 一种艾普拉唑镁晶型及其制备方法
KR102027388B1 (ko) * 2017-11-15 2019-10-01 주식회사 다산제약 고순도 일라프라졸 결정형 b의 제조방법
CN111187255B (zh) * 2020-01-13 2021-07-20 丽珠医药集团股份有限公司 右旋艾普拉唑钾盐的制备方法和右旋艾普拉唑的制备方法
KR20220065235A (ko) 2020-11-13 2022-05-20 주식회사 파마코스텍 일라프라졸 혼형 결정의 신규한 제조방법
KR102250509B1 (ko) * 2020-12-09 2021-05-11 유니셀랩 주식회사 새로운 일라프라졸/자일리톨 공결정
KR20210019469A (ko) 2021-02-02 2021-02-22 주식회사 파마코스텍 일라프라졸 나트륨 결정형 및 신규한 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090086121A (ko) * 2006-12-29 2009-08-10 일양약품주식회사 용매화 일라프라졸의 결정형
WO2008083319A1 (en) * 2006-12-29 2008-07-10 Il Yang Pharmaceutical Company, Ltd. Solid state forms of enantiopure ilaprazole

Also Published As

Publication number Publication date
EA019058B1 (ru) 2013-12-30
WO2011071314A3 (en) 2011-11-10
BR112012012212A2 (pt) 2015-09-08
IN2012DN03176A (ru) 2015-09-25
KR101144600B1 (ko) 2012-05-16
WO2011071314A2 (en) 2011-06-16
EA201200716A1 (ru) 2012-10-30
KR20110064545A (ko) 2011-06-15
UA102787C2 (ru) 2013-08-12

Similar Documents

Publication Publication Date Title
CO6541539A2 (es) Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas
AR076974A1 (es) Metodo para sintetizar pirfenidona
AR098260A2 (es) Polimorfo cristalino de una sal de bisulfato de un antagonista del receptor de trombina, proceso para su preparación, composición y forma purificada
EA201000147A1 (ru) Способ выделения и очистки монтелукаста
MY167395A (en) Method for producing glufosinate p free acid
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
AR076891A1 (es) Metodo para la preparacion de clorhidrato de nalmefeno
PE20061014A1 (es) Clorhidrato de lercanidipina amorfo
CU20120137A7 (es) Hidrato del hidrocloruro de agomelatina y preparación de éste
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
CO6700138A1 (es) Procedimiento de preparación de sal de l-arginina de perindoprilo
ES2571043T3 (es) Preparación de dihidropiridinas
MX2014004823A (es) Colorantes acidos de trisazo.
AR081659A1 (es) Procedimiento de obtencion de la forma cristalina ii del febuxostat
AR087344A1 (es) Formas polimorficas del acido 5-(3,3-dimetil-but-1-inil)-3-[(trans-4-hidroxi-ciclohexil)-(trans-4-metil-ciclohexancarbonil)-amino]-tiofen-2-carboxilico y su uso en el tratamiento de la hepatitis c
AR104145A1 (es) Método de producción de epirrubicina, intermediario y sal farmacéutica
CL2012001528A1 (es) Proceso para preparar la forma cristalina a de ilaprazol a partir de una sal inorganica de ilaprazol y posterior neutralizacion de la sal con un acido en un solvente de reaccion; y proceso para preparar la forma cristalina b de ilaprazol en la forma cristalina a de ilaprazol.
MX2010007923A (es) Forma cristalina de abacavir que esta esencialmente libre de disolvente.
CU20120136A7 (es) Hidrato del hidrobromuro de agomelatina y preparación de éste
AR094240A1 (es) Proceso para producir cristal de compuesto de pirazol
AR071804A1 (es) Cristales de sucralosa enjuagados con regulador (buffer)
TH137478B (th) กระบวนการสำหรับจัดเตรียมรูปแบบผลึก a และ b ของไอลาพราโซล และกระบวนการสำหรับการเปลี่ยนรูปแบบผลึก
CO6280533A2 (es) Proceso para preparar un compuesto intermedio para sintetizar un antiulcerante
BR112016006628A2 (pt) forma polimórfica de hiodesoxicolato de sódio (nahdc) e seu processo de preparação
TH137478A (th) กระบวนการสำหรับจัดเตรียมรูปแบบผลึก a และ b ของไอลาพราโซล และกระบวนการสำหรับการเปลี่ยนรูปแบบผลึก